Skip to main content
The BMJ logoLink to The BMJ
. 1993 Jul 17;307(6897):164–168. doi: 10.1136/bmj.307.6897.164

Case-control study of congenital anomalies in children of cancer patients.

L Dodds 1, L D Marrett 1, D J Tomkins 1, B Green 1, G Sherman 1
PMCID: PMC1678343  PMID: 8343744

Abstract

OBJECTIVES--To determine whether the offspring of cancer survivors are at an increased risk of congenital anomalies and whether cancer therapy before conception is associated with such an increase. DESIGN--Case-control study using computerised record linkage. SETTING--Ontario, Canada. SUBJECTS--Parents of children born during April 1979 to December 1986 who had a congenital anomaly diagnosed within the first year of life (45,200 mothers and 41,158 fathers) and a matched sample of parents whose children did not have a congenital anomaly (45,200 mothers and 41,158 fathers). MAIN OUTCOME MEASURES--Cancer diagnosed in either parent before conception and radiotherapy to the pelvis or abdomen or chemotherapy with an alkylating agent. RESULTS--Among the mothers, 54 cases and 52 controls were identified as having had cancer diagnosed in Ontario (relative risk = 1.04, 95% confidence interval 0.7 to 1.5) and among the fathers, 61 cases and 65 controls were identified (0.9, 0.7 to 1.4). No significant associations were found between congenital anomalies in the offspring and any type of cancer treatment in either the mothers or the fathers. CONCLUSIONS--The risk of congenital anomalies among liveborn offspring whose parents have had cancer or been treated for cancer is not higher than that in the general population.

Full text

PDF
164

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baird P. A., Anderson T. W., Newcombe H. B., Lowry R. B. Genetic disorders in children and young adults: a population study. Am J Hum Genet. 1988 May;42(5):677–693. [PMC free article] [PubMed] [Google Scholar]
  2. Byrne J., Mulvihill J. J., Myers M. H., Connelly R. R., Naughton M. D., Krauss M. R., Steinhorn S. C., Hassinger D. D., Austin D. F., Bragg K. Effects of treatment on fertility in long-term survivors of childhood or adolescent cancer. N Engl J Med. 1987 Nov 19;317(21):1315–1321. doi: 10.1056/NEJM198711193172104. [DOI] [PubMed] [Google Scholar]
  3. Czeizel A. Population surveillance of sentinel anomalies. Mutat Res. 1989 May;212(1):3–9. doi: 10.1016/0027-5107(89)90017-1. [DOI] [PubMed] [Google Scholar]
  4. Gardner M. J., Snee M. P., Hall A. J., Powell C. A., Downes S., Terrell J. D. Results of case-control study of leukaemia and lymphoma among young people near Sellafield nuclear plant in West Cumbria. BMJ. 1990 Feb 17;300(6722):423–429. doi: 10.1136/bmj.300.6722.423. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Green D. M., Zevon M. A., Lowrie G., Seigelstein N., Hall B. Congenital anomalies in children of patients who received chemotherapy for cancer in childhood and adolescence. N Engl J Med. 1991 Jul 18;325(3):141–146. doi: 10.1056/NEJM199107183250301. [DOI] [PubMed] [Google Scholar]
  6. Hawkins M. M. Is there evidence of a therapy-related increase in germ cell mutation among childhood cancer survivors? J Natl Cancer Inst. 1991 Nov 20;83(22):1643–1650. doi: 10.1093/jnci/83.22.1643. [DOI] [PubMed] [Google Scholar]
  7. Hawkins M. M. Long term survival and cure after childhood cancer. Arch Dis Child. 1989 Jun;64(6):798–807. doi: 10.1136/adc.64.6.798. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Hawkins M. M., Smith R. A. Pregnancy outcomes in childhood cancer survivors: probable effects of abdominal irradiation. Int J Cancer. 1989 Mar 15;43(3):399–402. doi: 10.1002/ijc.2910430309. [DOI] [PubMed] [Google Scholar]
  9. Howe G. R., Lindsay J. A generalized iterative record linkage computer system for use in medical follow-up studies. Comput Biomed Res. 1981 Aug;14(4):327–340. doi: 10.1016/0010-4809(81)90004-5. [DOI] [PubMed] [Google Scholar]
  10. Kirk M., Lyon M. F. Induction of congenital anomalies in offspring of female mice exposed to varying doses of X-rays. Mutat Res. 1982 Nov;106(1):73–83. doi: 10.1016/0027-5107(82)90191-9. [DOI] [PubMed] [Google Scholar]
  11. Li F. P., Gimbrere K., Gelber R. D., Sallan S. E., Flamant F., Green D. M., Heyn R. M., Meadows A. T. Outcome of pregnancy in survivors of Wilms' tumor. JAMA. 1987 Jan 9;257(2):216–219. [PubMed] [Google Scholar]
  12. Mulvihill J. J., McKeen E. A., Rosner F., Zarrabi M. H. Pregnancy outcome in cancer patients. Experience in a large cooperative group. Cancer. 1987 Sep 1;60(5):1143–1150. doi: 10.1002/1097-0142(19870901)60:5<1143::aid-cncr2820600537>3.0.co;2-e. [DOI] [PubMed] [Google Scholar]
  13. Mulvihill J. J. Sentinel and other mutational effects in offspring of cancer survivors. Prog Clin Biol Res. 1990;340C:179–186. [PubMed] [Google Scholar]
  14. Nomura T. X-ray- and chemically induced germ-line mutation causing phenotypical anomalies in mice. Mutat Res. 1988 Apr;198(2):309–320. doi: 10.1016/0027-5107(88)90008-5. [DOI] [PubMed] [Google Scholar]
  15. Trasler J. M., Hales B. F., Robaire B. Paternal cyclophosphamide treatment of rats causes fetal loss and malformations without affecting male fertility. Nature. 1985 Jul 11;316(6024):144–146. doi: 10.1038/316144a0. [DOI] [PubMed] [Google Scholar]
  16. Young J. L., Jr, Ries L. G., Silverberg E., Horm J. W., Miller R. W. Cancer incidence, survival, and mortality for children younger than age 15 years. Cancer. 1986 Jul 15;58(2 Suppl):598–602. doi: 10.1002/1097-0142(19860715)58:2+<598::aid-cncr2820581332>3.0.co;2-c. [DOI] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES